Michael S Perry Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

Michael S Perry is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 131,490 shares of ARWR, which is worth approximately $2.56 Million. The most recent transaction as insider was on Dec 18, 2024, when has been sold 16,733 shares (Common Stock) at a price of $22.99 per share, resulting in proceeds of $384,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K

14.58% 3M change

14.58% 12M change

Total Value Held $2.56 Million

MICHAEL S PERRY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2024	BUY Grant, award, or other acquisition	$384,691 $22.99 p/Share	16,733 Added 11.29%	131,490 Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	$380,819 $25.41 p/Share	14,987 Added 11.55%	114,754 Common Stock
Jan 10 2023	BUY Grant, award, or other acquisition	-	7,867 Added 7.31%	99,767 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	6,400 Added 6.51%	91,900 Common Stock
Jan 03 2022	SELL Open market or private sale	$293,490 $65.22 p/Share	4,500 Reduced 5.0%	85,500 Common Stock
Jan 04 2021	SELL Open market or private sale	$304,360 $76.09 p/Share	4,000 Reduced 4.26%	90,000 Common Stock Sold
Jan 01 2021	BUY Grant, award, or other acquisition	-	9,000 Added 8.74%	94,000 Common Stock

Also insider at

RCEL

AVITA Medical, Inc. Healthcare

Director

MSP

Michael S Perry

Director

Valencia, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Value

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Track Activities on ARWR

Account